Clin2
NCT07450430Possibly a fitNot yet recruiting

Best time to start ketamine for sickle cell pain

Sickle Cell DiseaseSickle Cell Crisis

Treatments studied

Part of Blood & lymphatic, Genetic & congenital, Pain clinical trials.

This trial tests when to start ketamine for children and teens with sickle cell disease who are in pain. It aims to find the best timing to help reduce pain in the emergency room or infusion clinic.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
90 people
Ages
6 years to 24 years
Study type
Interventional

Who can take part

  • You have been diagnosed with sickle cell disease
  • You are between 6 and 24 years old
  • You are currently having pain and are at the hospital or infusion clinic
  • You have no known allergy to ketamine
  • You have not had severe side effects from ketamine before

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07369024Recruiting· Phase 2
Study of low-dose ketamine for sickle cell pain crisis

This study tests whether a low-dose of ketamine (a pain medicine) can help children and young adults with sickle cell disease who are in a pain crisis. It aims to provide better pain relief while avoiding some side effects of standard painkillers.

Torrance, California
NCT06989567Not yet recruiting· Phase 3
L-citrulline for young people with sickle cell pain crisis

This trial tests an IV medication called L-citrulline for children, teens, and young adults (ages 6–21) with sickle cell disease who are having a sudden, severe pain crisis (called a vaso-occlusive crisis). The goal is to see if it helps relieve pain quickly.

Washington D.C., District of Columbia
NCT06579703Not yet recruiting· Phase 4
Ketorolac for sickle cell pain crisis in children

This trial tests a pain medicine called ketorolac (an NSAID) to see if it helps children with sickle cell disease who come to the emergency room or clinic with sudden, severe pain. If your child has sickle cell disease and is having an acute pain crisis, this study may be an option.

NCT06930703Recruiting· Phase 1/Phase 2
CBD for sickle cell pain

This trial tests if cannabidiol (CBD) can help reduce pain interference in adults with sickle cell disease. You will take CBD daily for 4 weeks and report your pain levels.

Manhattan, New York
NCT06635902Recruiting· Phase 2
Citrulline for sickle cell pain crisis

This trial tests if an intravenous medication called L-citrulline can help treat pain crises in children and young adults with sickle cell disease. Participants receive either the study drug or a placebo while in the hospital for a severe pain episode.

Washington D.C., District of Columbia
NCT06725550Recruiting
Acupuncture for pain in sickle cell disease

This trial tests whether adding acupuncture to standard pain treatments can help manage pain in people with sickle cell disease. It involves brain scans, questionnaires, and acupuncture sessions to see if this approach reduces pain and improves quality of life.

Cincinnati, Ohio

Hear when a new Sickle Cell Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.